Shots:
The EC has approved Sephience (sepiapterin) to treat PKU in pts of all ages and disease severities across all 30 EEA states; launch is anticipated in Germany in H1 of July
Approval was based on APHENITY study results and long-term extension data showing durable effects and improved dietary flexibility
Sephience is an oral synthetic…
